Epigenetic regulation depends on the interplay between chromatin accessibility and DNA methylation — two layers of information that are typically measured by separate assays on fragmented DNA. Single-molecule accessible chromatin and methylation sequencing (SMAC-Seq) breaks this limitation by combining enzymatic labeling of open chromatin with Oxford Nanopore long-read sequencing to simultaneously profile chromatin accessibility, native DNA methylation, and genetic sequence on individual DNA molecules. CD Genomics offers a comprehensive SMAC-Seq service that delivers kilobase-scale single-molecule epigenetic multi-omics from a single experiment.
Our SMAC-Seq platform uses sequence-nonspecific methyltransferases — EcoGII for m6A labeling of accessible chromatin, with optional M.CviPI (GpC methylation) and M.SssI (CpG methylation) for combined accessibility-methylation analysis. After high-molecular-weight DNA extraction, Nanopore long-read sequencing detects these exogenous modifications alongside endogenous DNA methylation at single-molecule resolution. This approach provides chromatin accessibility at ~3–5 bp theoretical resolution, captures coordinated accessibility across distal regulatory elements up to 100 kb apart, and simultaneously reports native 5-methylcytosine (5mC) patterns — all without fragmentation, bisulfite conversion, or amplification.
SMAC-Seq (Single-Molecule long-read Accessible Chromatin mapping Sequencing) profiles chromatin accessibility and DNA methylation simultaneously on individual DNA molecules at multi-kilobase scales. The core principle involves treating intact nuclei with sequence-nonspecific DNA methyltransferases that preferentially modify accessible (open) chromatin regions while nucleosome-bound or protein-protected DNA remains unmodified. After high-molecular-weight DNA extraction, Oxford Nanopore long-read sequencing directly detects both the exogenous and endogenous base modifications from the raw ionic current signal, providing single-molecule resolution of chromatin states across multi-kilobase genomic distances.
The key advantage of SMAC-Seq over conventional short-read methods (ATAC-seq, DNase-seq) is its ability to profile accessible chromatin on native DNA molecules without fragmentation. This preserves the long-range connectivity between distal regulatory elements — promoters, enhancers, insulators — enabling analysis of coordinated chromatin states across tens to hundreds of kilobases on individual DNA fibers. SMAC-Seq simultaneously captures endogenous DNA methylation (5mC in CpG context), delivering multi-modal epigenetic profiles from a single experiment. For complementary epigenomic approaches, explore our Epigenetics and Methylation Analysis platform.
m6A-SMAC-Seq (EcoGII only): Uses EcoGII methyltransferase to label accessible chromatin at all adenine residues (N6-methyladenosine / m6A). Ideal for human and mammalian samples where endogenous CpG methylation is already present, as EcoGII labeling does not interfere with 5mC detection. Provides the highest resolution (~3–5 bp), enabling transcription factor footprinting analysis at single-molecule resolution.
m6A-CpG-GpC-SMAC-Seq (EcoGII + M.CviPI + M.SssI): Combines three methyltransferases for simultaneous accessibility profiling and comprehensive methylation analysis. M.CviPI methylates GpC contexts and M.SssI methylates CpG contexts (both producing 5mC). This variant is particularly suitable for organisms with minimal endogenous DNA methylation (yeast, Drosophila) and for studies requiring both exogenous accessibility marks and endogenous methylation detection in a single assay.
SMAC-Seq operates on native, high-molecular-weight DNA without fragmentation, preserving the physical connectivity of chromatin states across individual DNA molecules. This enables direct observation of coordinated accessibility patterns between distal regulatory elements — promoters, enhancers, insulators — at distances up to 100 kb or more. Short-read methods (ATAC-seq, DNase-seq) lose this connectivity during fragmentation, requiring computational imputation to infer long-range relationships.
A single SMAC-Seq experiment produces three layers of information: (1) chromatin accessibility via exogenous methyltransferase labeling, (2) endogenous DNA methylation (5mC) from unlabeled CpG sites, and (3) genetic sequence for variant detection and haplotype phasing. This eliminates the need for separate ATAC-seq, WGBS, and WGS experiments, conserving sample material and simplifying project logistics.
Nanopore sequencing directly detects modified bases from raw ionic current without PCR amplification bias, preserving native modification stoichiometry. EcoGII labeling provides theoretical resolution of ~3–5 bp, enabling transcription factor footprinting that short-read accessibility methods cannot match at native DNA length scales.
SMAC-Seq eliminates the need for separate ATAC-seq, WGBS, and whole-genome sequencing experiments. One library preparation, one sequencing run, and one bioinformatics pipeline deliver chromatin accessibility, DNA methylation, and genetic variation data simultaneously — conserving samples, reducing total sequencing costs, and simplifying project management.
We deliver both aggregate-level accessibility and methylation tracks that are compatible with existing short-read analysis frameworks, alongside single-molecule chromatin state calls that reveal epigenetic heterogeneity, phased epigenotypes, and coordinated long-range regulation invisible to bulk methods. Our Long-Read Sequencing Data Analysis pipeline handles all stages of modification calling and downstream interpretation.
We support all SMAC-Seq enzyme variants — m6A-only (EcoGII) for transcription factor footprinting, or multi-enzyme (EcoGII + M.CviPI + M.SssI) for comprehensive accessibility-methylation analysis. This flexibility allows researchers to match the epigenomic approach exactly to their organism and biological question.
SMAC-Seq works across all eukaryotes with intact nuclei — from yeast and plants to mammalian cells and tissues — with protocol adjustments for nuclei isolation and enzyme permeability. This cross-species versatility is complemented by our related long-read epigenomics services including Long-Read Sequencing of DNA Methylation and Fiber-Seq.
Intact nuclei are isolated from cells or tissue under conditions that preserve native chromatin structure. The nuclei are treated with sequence-nonspecific DNA methyltransferases — EcoGII (methylates all adenine residues to m6A), optionally combined with M.CviPI (GpC methylation to 5mC) and M.SssI (CpG methylation to 5mC). These enzymes preferentially modify DNA in open/accessible chromatin regions, while nucleosome-bound DNA and transcription factor-occupied sites are protected from methylation.
After enzymatic labeling, high-molecular-weight (HMW) genomic DNA is extracted using gentle methods (MagAttract HMW DNA Kit or phenol-chloroform with wide-bore pipetting) that preserve DNA fragments exceeding 50–100 kb. DNA quality and size distribution are verified by pulsed-field gel electrophoresis or TapeStation analysis before library preparation.
HMW DNA is prepared for Oxford Nanopore sequencing using the Ligation Sequencing Kit to maximize read length, or Rapid Barcoding Kit for multiplexed experiments. Libraries are loaded onto PromethION or MinION flow cells, generating reads averaging 10–30 kb with maximum read lengths exceeding 100 kb. The raw ionic current signal is simultaneously processed for modified base detection (m6A, 5mC) alongside canonical base calling.
Figure 1. SMAC-Seq experimental and bioinformatics workflow: intact nuclei are isolated and treated with sequence-nonspecific methyltransferases (EcoGII ± M.CviPI ± M.SssI) that label accessible chromatin regions. High-molecular-weight DNA is extracted and sequenced on Oxford Nanopore platforms. Modified base detection (m6A, 5mC) from raw ionic current data generates per-base modification frequencies, single-molecule chromatin state classifications, nucleosome positioning calls, and transcription factor footprints.
Raw ionic current data are basecalled using ONT Dorado with modified base detection models (5mC + 5hmC + 6mA). Reads are aligned to the reference genome using minimap2. Per-base modification frequencies are calculated for both exogenous (accessibility) and endogenous (methylation) marks. Chromatin accessibility at individual molecules is classified by detecting contiguous stretches of unmodified DNA (protected by nucleosomes or proteins) interspersed with modified regions (open chromatin). For related methods combining long reads with epigenetic analysis, see our Chromatin Conformation services.
| Analysis Feature | Basic | Advanced |
| Dorado basecalling with modified base detection (5mC + 5hmC + 6mA) | ✓ | ✓ |
| Genome alignment (minimap2) and sequencing QC | ✓ | ✓ |
| Per-base modification frequency (5mC, 6mA) tracks | ✓ | ✓ |
| Chromatin accessibility track (exogenous modification density) | ✓ | ✓ |
| Single-molecule chromatin state classification (open / closed / protected) | ✓ | ✓ |
| Nucleosome positioning analysis on single molecules | ✓ | ✓ |
| Transcription factor footprint detection | — | ✓ |
| Coordinated long-range accessibility analysis (enhancer–promoter) | — | ✓ |
| Allele-specific accessibility and methylation analysis | — | ✓ |
| Haplotype-resolved epigenomic profiling | — | ✓ |
| Integration with short-read ATAC-seq or WGBS data | — | ✓ |
| Custom visualization and publication-ready figures | — | ✓ |
SMAC-Seq occupies a unique position in the epigenomics toolkit, combining single-molecule resolution, multi-modal profiling, and long-range connectivity in a single assay. The table below compares SMAC-Seq with conventional short-read methods across key performance dimensions.
| Feature | SMAC-Seq | ATAC-seq | WGBS | WGS |
| Read length | Multi-kilobase (>10 kb) | Short (50–150 bp) | Short (50–150 bp) | Short (50–150 bp) |
| Chromatin accessibility | ✔ Single-molecule + aggregate | ✔ Aggregate only | ✘ Not measured | ✘ Not measured |
| DNA methylation | ✔ Endogenous 5mC | ✘ Not measured | ✔ CpG methylation | ✘ Not measured |
| Genetic variation | ✔ SNV + SV detection | ✘ Limited | ✘ Limited | ✔ Full genome |
| Long-range connectivity | ✔ Direct on native DNA | ✘ Lost in fragmentation | ✘ Lost in fragmentation | ✘ Lost in fragmentation |
| Amplification | ✔ No PCR (amplification-free) | ✘ PCR required | ✘ Bisulfite conversion + PCR | ✘ PCR required |
| Best for | Single-molecule multi-omics (accessibility + methylation + sequence) | Bulk chromatin accessibility | Bulk DNA methylation | Genome sequence + variants |
| Category | Requirement | Notes |
| Sample type | Cultured cells (adherent or suspension); fresh or flash-frozen tissue | Nuclei integrity essential for accurate accessibility labeling; RNase-free conditions recommended |
| Minimum input | ≥1×106 cells (standard); ≥5×105 cells (optimized) | Cell number depends on genome size; higher input recommended for single-molecule analysis depth |
| Sample quality | High viability (>90%); intact nuclei preparation | Damaged nuclei lead to non-specific methylation labeling and reduced data quality |
| Species compatibility | All eukaryotes with intact nuclei | Protocol adjustments for yeast, plant, insect, and mammalian cells available |
| Recommended depth | 10–20× genome coverage (human); higher for single-molecule analysis | Coverage requirements scale with genome size; higher depth improves single-molecule resolution |
| Enzyme variant | m6A-SMAC-Seq (EcoGII) or m6A-CpG-GpC-SMAC-Seq (EcoGII + M.CviPI + M.SssI) | Selected based on organism and biological question; consult with project scientists for recommendations |
For detailed instructions on sample preparation and shipping, please refer to our Sample Submission Guidelines.
Expertise in long-read epigenetic analysis
CD Genomics has deep experience in both long-read sequencing and epigenetic modification detection. Our team understands the biochemical requirements for successful SMAC-Seq — from nuclei isolation and methyltransferase labeling optimization through HMW DNA extraction and Nanopore modification calling — and has optimized each step for consistent, reproducible results across diverse eukaryotic species.
Flexible enzyme variant selection tailored to your research
We support both m6A-SMAC-Seq and m6A-CpG-GpC-SMAC-Seq approaches, allowing researchers to select the optimal enzyme combination for their organism and biological question — from transcription factor footprinting in human cells to comprehensive accessibility-methylation analysis in non-model organisms.
End-to-end project support from experiment to epigenomic analysis
We manage every stage of your SMAC-Seq project: feasibility assessment and experiment design, cell culture and nuclei isolation, methyltransferase labeling optimization, HMW DNA extraction, ONT sequencing on PromethION instruments, and a comprehensive bioinformatics pipeline delivering single-molecule chromatin state annotations, modification tracks, and long-range regulatory analysis.
Integrated long-read multi-omics platform
Our platform spans the full spectrum of long-read genomics and epigenomics — from SMAC-Seq and Fiber-Seq for single-molecule epigenetics to whole-genome sequencing, structural variation detection, and full-length transcriptome analysis — providing a complete toolkit for multi-omic research.
Tu K, Li X, Zhang Q, Huang W, Xie D. A data-adaptive method for detecting exogenous methyltransferase-accessible chromatin using nanopore sequencing. Bioinformatics. 2024;40(5):btae206. DOI: 10.1093/bioinformatics/btae206. (CC BY 4.0)
SMAC-Seq data analysis faces three key challenges: endogenous DNA methylation can be confused with exogenous labeling signals, non-open-chromatin-specific exogenous methylation introduces noise, and nanopore base-calling errors affect per-base modification calls. Existing methods lack data-adaptive strategies to distinguish true chromatin accessibility signals from these confounding factors, particularly in repetitive genomic regions where short-read methods are blind. The authors developed MAGNIFIER (Methyltransferase Accessible Genome Region Finder) to address these challenges using a hierarchical latent variable model.
MAGNIFIER employs a hierarchical latent variable model that integrates co-methylation scores across neighboring sites to reduce noise, predicts locus-specific null distributions to account for regional background methylation, determines per-read modification status (Z) at each candidate base using data-adaptive thresholds, and computes chromatin accessibility scores from the aggregated per-read status. The model was trained and validated on SMAC-Seq data (EcoGII-treated nuclei followed by Nanopore sequencing) from human K562 and GM12878 cell lines, with ATAC-seq and DNase-seq data used as ground truth for performance benchmarking.
Figure 1. MAGNIFIER workflow for SMAC-Seq data analysis. (A) Overview of the hierarchical latent variable model describing the relationship between exogenous methylation, endogenous methylation, and chromatin accessibility. (B) Calculation of co-methylation score to quantify coordinated modification across neighboring sites. (C) Prediction of null distribution for each candidate base site using a data-adaptive approach. (D) Identification of locus-specific stage cutoff and per-read modification status (Z) for each candidate base showing the genomic structure of exogenous methylation signal. (E) Prediction of per-site exogenous modification stage based on aggregated per-read status Z. (F) Calculation of chromatin accessibility scores from exogenous modification calls. Adapted from Tu K, et al. Bioinformatics. 2024;40(5):btae206. (CC BY 4.0)
The MAGNIFIER study demonstrates that dedicated computational approaches significantly enhance the value of SMAC-Seq data by accurately detecting chromatin accessibility across all genomic contexts, including repetitive regions inaccessible to short-read methods. By addressing the unique analytical challenges of exogenous methyltransferase labeling combined with nanopore long-read sequencing, MAGNIFIER provides a robust framework for extracting biological insights from SMAC-Seq experiments and highlights the technology's potential for comprehensive epigenomic analysis beyond the limits of traditional approaches.
ATAC-seq uses Tn5 transposase to fragment and tag open chromatin, generating short reads (50–150 bp) that provide aggregate accessibility profiles but lose all long-range connectivity. SMAC-Seq uses methyltransferase labeling on intact native DNA followed by Nanopore long-read sequencing, preserving multi-kilobase single-molecule information and simultaneously reporting DNA methylation status. SMAC-Seq also captures endogenous 5mC methylation alongside accessibility, which ATAC-seq cannot provide.
Choose m6A-SMAC-Seq (EcoGII only) for transcription factor footprinting and highest-resolution accessibility analysis in human or mammalian samples where endogenous CpG methylation is already present. Choose m6A-CpG-GpC-SMAC-Seq (EcoGII + M.CviPI + M.SssI) for organisms with minimal endogenous methylation (yeast, Drosophila) or when you need comprehensive accessibility and methylation profiling from a single experiment. Our project scientists can help determine the optimal variant for your specific research question.
Our standard SMAC-Seq service generates average read lengths of 10–30 kb, with maximum read lengths exceeding 100 kb depending on DNA quality and library preparation method. This is sufficient to span most gene loci and capture coordinated accessibility across distal regulatory elements including enhancer-promoter pairs separated by tens of kilobases. Read length optimization is available through protocol adjustments and HMW DNA extraction method selection.
Yes. m6A-SMAC-Seq using EcoGII provides theoretical resolution of ~3–5 bp, enabling detection of transcription factor binding events as short protected regions within broader open chromatin domains. Our advanced bioinformatics pipeline includes dedicated footprinting analysis that aggregates single-molecule protection patterns across thousands of aligned molecules to identify condition-specific transcription factor occupancy at known and de novo motif sites.
Standard deliverables include basecalled FASTQ files, genome-aligned BAM files with modification tags, per-base modification frequency tracks (BigWig format), chromatin accessibility coverage tracks, single-molecule chromatin state annotations (open/closed/protected regions per molecule), and a comprehensive project report. Advanced analysis adds transcription factor footprinting, long-range coordinated accessibility analysis between distal regulatory elements, allele-specific epigenetic profiling, and custom visualization for publication-ready figures.
Deliverable 1 — Single-molecule chromatin accessibility tracks
IGV genome browser view showing per-molecule modification patterns across a gene locus, with open chromatin (methylated) and closed/protected (unmethylated) segments color-coded along each aligned read. Individual DNA molecules are displayed as parallel tracks, revealing heterogeneity in chromatin states across the cell population.
Deliverable 2 — Per-base modification frequency tracks
Genome browser tracks for both exogenous (6mA accessibility) and endogenous (5mC methylation) modifications, displayed as continuous frequency profiles across genomic coordinates. Aggregate tracks are directly comparable to short-read ATAC-seq and WGBS data for validation and integration.
Deliverable 3 — Single-molecule chromatin state classification
Color-coded molecule-level view distinguishing open chromatin (red), nucleosome-bound (blue), and transcription factor-protected (green) regions along each DNA molecule, with aggregate state enrichment plots at annotated regulatory elements.
Deliverable 4 — Transcription factor footprinting analysis
Aggregated methylation protection profiles at transcription factor binding motifs, showing characteristic dip patterns at occupied sites. Condition-specific footprint depth comparisons reveal differential transcription factor occupancy across experimental conditions.
Deliverable 5 — Long-range coordinated accessibility analysis
Correlation matrices and molecule-level views showing coordinated open/closed chromatin states between distal enhancer-promoter pairs, enabling identification of regulatory interactions maintained on individual DNA molecules.
References